The efficacy of acupressure to prevent anti-tuberculosis drugs-induced adverse effects in pulmonary tuberculosis patients

The efficacy of acupressure to prevent anti-tuberculosis drugs-induced adverse effects in pulmonary tuberculosis patients: a randomised parallel trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN93554714

Enrollment

130

Registered

2015-05-02

Start date

2015-04-29

Completion date

Unknown

Last updated

2019-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary tuberculosis Infections and Infestations Tuberculosis

Interventions

Participants are randomized to the experimental and control groups. All participants undergo an acupressure program for 15 minutes per day, five days per week, for four weeks. The experimental group a

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Pulmonary tuberculosis patients aged 20 years old or over

Exclusion criteria

Exclusion criteria: Has cancer, severe liver or renal disease, extra-pulmonary TB, and consciousness unclear

Design outcomes

Primary

Measure	Time frame
1. Adverse drug effects; the research assistant will collect the data from patients’ self-report, like the type, frequency and severity of adverse drug effects 2. Physiological changes 3. Patient’s adherence, using their medical charts All outcomes will be measured at baseline, and every month until they complete their treatment	—

Secondary

Measure	Time frame
1. Health-related quality of life, using the Short-Form-36 Health Survey 2. Cure rate, using medical charts All outcomes will be measured at baseline, and every month until they completed their treatment	—

Countries

Taiwan

Contacts

Public ContactChia-Ju Hsieh

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026